1. 103. The prognostic significance of chemotherapy response score and lymphocytic infiltration in patients with ovarian cancer treated with neoadjuvant chemotherapy. (March 2022) Authors: Rodolakis, J.; Prodromidou, A.; Thomakos, N.; Sotiropoulou, M.; Liontos, M.; Haidopoulos, D.; Rodolakis, A.; Loutradis, D.; Bamias, A. Journal: European journal of obstetrics, gynecology, and reproductive biology Issue: Volume 270(2022) Page Start: e34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2608 A retrospective study of vascular thromboembolic events (VaTEs) in patients receiving first line treatment for advanced urothelial cancer (AUC). (September 2015) Authors: Dimitriadis, I.; Tsironis, G.; Tzannis, K.; Koutsoukos, K.; Kostouros, E.; Liontos, M.; Lykka, M.; Trajce, E.; Nikolopoulos, K.; Sfika, A.; Kafantari, E.; Zagouri, F.; Matsouka, C.; Dimopoulos, M.A.; Bamias, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Survival Outcomes of Epithelial Ovarian Cancer Patients Following Dose-dense Versus 3-Weekly Platinum–Paclitaxel Chemotherapy: A Meta-Analysis. Issue 2 (February 2023) Authors: Pergialiotis, V.; Liatsou, E.; Thomakos, N.; Liontos, M.; Frountzas, M.; Papapanagiotou, A.; Rodolakis, A.; Haidopoulos, D. Journal: Clinical oncology Issue: Volume 35:Issue 2(2023) Page Start: e189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The emerging role of BET inhibitors in breast cancer. (October 2020) Authors: Andrikopoulou, A.; Liontos, M.; Koutsoukos, K.; Dimopoulos, MA.; Zagouri, F. Journal: Breast Issue: Volume 53(2020) Page Start: 152 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗